Lv11
30 积分 2026-09-01 加入
Systemic inflammation with myelodysplastic features: VEXAS syndrome
19分钟前
求助中
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study
1个月前
已完结
A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML
1个月前
已完结
Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry
1个月前
已完结
Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS
1个月前
已完结
Predicting the risk of venous thromboembolism in newly diagnosed myeloma with immunomodulatory drugs: External validation of the IMPEDE VTE score
2个月前
已完结
Prevalence and Survival Impact of Venous and Arterial Thrombosis among Multiple Myeloma Patients in Single Tertiary Care Center of Thailand: 5-Year Retrospective Review
2个月前
已完结
Thromboprophylaxis in multiple myeloma: a case-based review with practical guidelines
2个月前
已完结
Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasone
2个月前
已完结